Pratt Collard Advisory Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$1.88M Buy
22,527
+3,181
+16% +$260K 1.25% 25
2021
Q1
$1.46M Buy
19,346
+3,910
+25% +$285K 1.04% 30
2020
Q4
$1.05M Buy
15,436
+576
+4% +$37.5K 0.77% 38
2020
Q3
$867K Buy
14,860
+575
+4% +$35.8K 0.71% 42
2020
Q2
$928K Buy
14,285
+1,170
+9% +$73.7K 0.83% 38
2020
Q1
$778K Buy
13,115
+1,955
+18% +$131K 0.78% 41
2019
Q4
$829K Sell
11,160
-175
-2% -$12.3K 0.63% 47
2019
Q3
$715K Buy
11,335
+460
+4% +$27.3K 0.56% 53
2019
Q2
$593K Buy
10,875
+1,980
+22% +$107K 0.47% 58
2019
Q1
$480K Buy
8,895
+1,860
+26% +$115K 0.38% 67
2018
Q4
$461K Buy
+7,035
New +$525K 0.42% 63

Other funds holding CVS

Pratt Collard Advisory Partners's CVS Position: Q2 2021 in Review

Pratt Collard Advisory Partners increased its CVS Health (CVS) stake by 16% in Q2 2021, buying an estimated $260K and bringing the position to 22,527 shares worth $1.88M. The position accounts for 1.25% of the portfolio, ranked #25.

Pratt Collard Advisory Partners first reported a position in CVS in Q4 2018 and has held it in 11 quarters since. 2,065 funds tracked by Wall St. Rank hold CVS as of Q2 2021.

  • Pratt Collard Advisory Partners held 22,527 shares of CVS Health worth $1.88M as of Q2 2021.
  • Pratt Collard Advisory Partners bought 3,181 CVS Health shares in Q2 2021, an estimated $260K.
  • CVS Health made up 1.25% of Pratt Collard Advisory Partners's portfolio in Q2 2021, its #25 holding.
  • Pratt Collard Advisory Partners first reported a position in CVS Health in Q4 2018 and has held it in 11 quarters since.
  • 2,065 funds tracked by Wall St. Rank held CVS Health as of Q2 2021.

Based on Pratt Collard Advisory Partners's 13F filing for Q2 2021, filed 14 Jul 2021.